Skip to main content
Guttmacher Institute

Search

  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
Guttmacher Institute
Donate

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact
Video
July 19, 2024

Guttmacher acting co-CEO on the importance of ensuring access to medication abortion at US Senate

Destiny Lopez (Co-President and CEO), at the US Senate, urges maintaining access to medication abortion—now two-thirds of all abortions in the US—especially through telehealth in rural areas, emphasizing its safety and critical role post-Dobbs. 

Video

Transcript: Senator Lisa Murkowski: What can we do practically, right now, to help ameliorate some of what we are seeing with the impact of the Dobbs decision to ensure that women do have access to the care they need now? Ms. Lopez, go ahead. Yeah, I'm happy to answer.  

Destiny Lopez: Thank you for the question. One of the things we can do, Senator, is ensure that we can maintain access to medication abortion. Right? Medication abortion now accounts for two-thirds of all abortions in this country as of 2023. And in rural areas like yours, it's incredibly important to have that option via telehealth for folks who can't reach a provider, or when they live in communities as the doctor said, that don't have providers given the limited access to providers that they have and so maintaining access to a method that we know is safe and effective based on decades of widespread use and study, I think becomes critically important. Thank you for saying that. I absolutely agree. Thank you, Ms. Chairman.  

Senator Lisa Murkowski: Thank you. 

Share

Guttmacher Institute

Center facts. Shape policy.
Advance sexual and reproductive rights.®

Donate Now
Newsletter Signup  Contact Us 
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Footer

  • Privacy Policy
  • Accessibility Statement
© 2026 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.